When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Testicular cancer

Last reviewed: 13 Dec 2025
Last updated: 04 Mar 2025

Summary

Definition

History and exam

Key diagnostic factors

  • age 20 to 34 years
  • testicular mass
Full details

Other diagnostic factors

  • extratesticular manifestation
Full details

Risk factors

  • cryptorchidism
  • gonadal dysgenesis
  • family history of testicular cancer
  • personal history of testicular cancer
  • testicular atrophy
  • white ethnicity
  • HIV infection
  • occupational exposures
  • inguinal hernia
  • genetic abnormality
Full details

Diagnostic investigations

1st investigations to order

  • ultrasound with color Doppler of testis
  • chest imaging
  • CT scan abdomen and pelvis with contrast
  • serum beta-human chorionic gonadotropin (beta-hCG)
  • serum alpha-fetoprotein (AFP)
  • serum lactate dehydrogenase (LDH)
  • histologic exam of testicular mass postorchiectomy
Full details

Investigations to consider

  • serum placental alkaline phosphatase
  • MRI abdomen and pelvis
  • CT scan chest
  • biopsy of contralateral testis
Full details

Treatment algorithm

INITIAL

suspicious testicular mass

ACUTE

early-stage seminoma

early-stage nonseminoma

ONGOING

seminoma or nonseminoma: stage IIC or stage III disease

seminoma or nonseminoma: relapse disease

Contributors

Authors

Al B. Barqawi, MD, FRCS

Professor of Surgery/Urology

University of Colorado Anschutz Medical Campus

Aurora

CO

Disclosures

ABB declares that he has no competing interests.

Corbin J. Eule, MD

Assistant Professor of Medical Oncology

University of Colorado Anschutz Medical Campus

Aurora

CO

Disclosures

CJE declares that he has no competing interests.

Acknowledgements

Dr Al B. Barqawi and Dr Corbin J. Eule would like to gratefully acknowledge Dr Elizabeth R. Kessler, Dr Thomas W. Flaig, and Dr Brandon Bernard, previous contributors to this topic.

Disclosures

ERK, TWF, and BB declare that they have no competing interests.

Peer reviewers

Elisabeth Heath, MD

Assistant Professor of Medicine and Oncology

Karmanos Cancer Institute

Wayne State University

Detroit

MI

Disclosures

EH declares that she has no competing interests.

Gianfilippo Bertelli, MD, PhD, FRCP (Edin)

Consultant/Honorary Senior Lecturer in Medical Oncology

SW Wales Cancer Institute/Department of Oncology

Singleton Hospital

Sketty

Swansea

UK

Declarações

GB declares that he has no competing interests.

Emilio Porfiri, MD, PhD

Senior Lecturer in Medical Oncology

School of Cancer Sciences

University of Birmingham

Birmingham

UK

Declarações

EP declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Stephenson A, Bass EB, Bixler BR, et al. Diagnosis and treatment of early-stage testicular cancer: AUA guideline amendment 2023. J Urol. 2024 Jan;211(1):20-5.Texto completo  Resumo

European Association of Urology. Testicular cancer. 2024 [internet publication].Texto completo

Oldenburg J, Berney DM, Bokemeyer C, et al. Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022 Apr;33(4):362-75.Texto completo  Resumo

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: testicular cancer [internet publication].Texto completo

American College of Radiology. ACR appropriateness criteria: staging and surveillance of testicular cancer. 2021 [internet publication].Texto completo

Gillessen S, Sauvé N, Collette L, et al. Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium. J Clin Oncol. 2021 May 10;39(14):1563-74.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Testicular cancer images
  • Diagnósticos diferenciais

    • Testicular torsion
    • Epididymo-orchitis
    • Scrotal hernia
    Mais Diagnósticos diferenciais
  • Guidelines

    • NCCN clinical practice guidelines in oncology: testicular cancer
    • Diagnosis and treatment of early stage testicular cancer
    Mais Guidelines
  • Patient information

    Testicular cancer

    Testicular cancer: questions to ask your doctor

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer